Alliances
There has been a string of news stories about how big pharma is teaming up with various artificial intelligence (AI) companies to leverage real-world data and speed drug development.
Blythedale Children’s Hospital and Burke Neurological Institute announce the appointment of Dianna E. Willis, Ph.D., as Director of Research for the Burke-Blythedale Pediatric Neuroscience Research Collaboration.
Organ-on-Chip specialist CN Bio has signed a distribution agreement with Sydney-based AXT Pty. Ltd., Australia’s leading supplier of high technology scientific equipment.
Collaboration covers proposed trastuzumab biosimilar in Phase III development for human epidermal growth factor receptor 2 positive (HER2+) breast and gastric tumors
Pharma, biotech and life science companies from across the globe share data and progress on pipelines and other company events.
Codexis’ breakthrough enzyme cascade system enables better-tasting stevia product launch
NHS England will acquire hepatitis C drugs from the companies at competitive prices and work to identify patients around the country.
Calixar SAS announces that it has entered into an exclusive licensing agreement with Regeneron Pharmaceuticals, Inc.
Calixar is providing Regeneron exclusive rights to its technology and expertise. Regeneron plans to work on developing antibodies against an undisclosed target in several different therapeutic areas.
Aqilion searches for early innovative pharmaceutical projects that are based on solid research resting on a firm biological foundation and offering both clinical relevance and patient benefit.
PRESS RELEASES